Insider Cluster (2 insiders) ·Filed Aug 4, 2026

XERS

Xeris Biopharma Holdings, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago
Insider cluster: 2 insiders, $254K total
Actionable Insight • Neutral

This insider cluster is too small to warrant a trading signal. Monitor for larger C-suite transactions or a material corporate event (e.g., earnings, pipeline update) that could provide context for any future insider activity.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
XERS ▲ +2.93% at T+20d
NEUTRAL call ✓ call won +2.93% · α vs SPY +4.17% · entry $8.19 → $8.43
Next anchor: T+60d in 25d
Latest observation: T+40 +7.42% FF3 residual α
Entry anchored
Aug 3, 03:59 PM ET
via exchange tick
T+1d
-0.98%
call -0.98% · α -0.78%
$8.11
settled 8w ago
T+5d
+2.44%
call +2.44% · α +2.54%
$8.39
settled 8w ago
T+20d
+2.93%
call +2.93% · α +4.17%
$8.43
settled 5w ago
T+60d
—
call — · α —
—
in 25d

Price Chart

Loading chart...

Executive Summary

Two non-C-suite insiders at Xeris Biopharma sold a combined $254K in open-market transactions over a 7-day window. The total value represents just 0.018% of the company's $1.4B market cap, making this a routine and immaterial cluster with no predictive signal.

Key Financial Metrics

Direction
selling
Total Value
$253.8K
Insiders
2

Key Facts

  • Two insiders (Beth Hecht and Kevin McCulloch, both 'See Remarks') sold shares on August 3, 2026.
  • Total sale value: $253,793 (Hecht: $133,553; McCulloch: $120,240).
  • Sales represent ~0.018% of Xeris's $1.4B market cap — well below the 0.1% materiality threshold.
  • Both transactions were open-market sales; no 10b5-1 plan or regular pattern noted.

Financial Impact

Negligible — $254K in insider sales is less than 0.02% of market cap.

Risk Factors

  • Insider sales at this trivial level carry no informational content; no bearish read-through.
  • Larger insider sales or a cluster exceeding 0.5% of market cap would be a more meaningful signal.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (13 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-XERS-1785901908217
14 reports for XERS
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+60▲ +24.89%Jun 12, 2026
Filters
Rows
Reports for XERS — sortable, filterable
TypeNow
Sep 9, 2026
23d ago
8-K
BULLISH ★ 6/10
$7.71 $7.78▲ +0.91%▲ +1.56%$9.08 (+17.77%)
Sep 1, 2026
4w ago
Insider Cluster
NEUTRAL ★ 3/10
$8.58 $7.67▼ −10.61%▼ −9.65%$9.08 (+5.83%)
Aug 6, 2026
8w ago
8-K
BULLISH ★ 7/10
$7.36 $8.33▲ +13.18%▲ +11.97%$9.08 (+23.37%)
Aug 4, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$8.19 $8.39▲ +2.44%▲ +2.54%$9.08 (+10.87%)
Jul 7, 2026
12w ago
Insider Cluster
BEARISH ★ 4/10
$8.94 $8.28▲ +7.38%▲ +7.93%$9.08 (−1.57%)
Jul 2, 2026
13w ago
3
NEUTRAL ★ 3/10
$8.28 $8.62▲ +4.11%▲ +3.18%$9.08 (+9.66%)
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 4/10
$8.28 $8.62▲ +4.11%▲ +3.18%$9.08 (+9.66%)
Jun 30, 2026
13w ago
8-K
NEUTRAL ★ 2/10
$8.00 $8.94▲ +11.75%▲ +11.49%$9.08 (+13.50%)
Jun 12, 2026
16w ago
Institutional Cluster
BULLISH ★ 4/10
$6.79 $6.95▲ +2.36%▲ +1.68%$9.08 (+33.73%)
Jun 5, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$6.24 $6.88▲ +10.26%▲ +8.14%$9.08 (+45.51%)
Showing 10 of 14

US Market Status

Market Closed — Opens Mon (64h 20m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 5, 2026